Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer
Posted On Wednesday, July 09, 2025
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
Posted On Wednesday, July 09, 2025
Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors
Posted On Wednesday, July 09, 2025
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
Posted On Wednesday, July 09, 2025
Salarius Pharmaceuticals’ Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies
Posted On Wednesday, July 09, 2025
THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery
Posted On Wednesday, July 09, 2025
Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law
Posted On Wednesday, July 09, 2025
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
Posted On Wednesday, July 09, 2025
Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution
Posted On Wednesday, July 09, 2025
New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials
Posted On Wednesday, July 09, 2025
Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway
Posted On Wednesday, July 09, 2025
DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
Posted On Wednesday, July 09, 2025
Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates
Posted On Wednesday, July 09, 2025
Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)
Posted On Wednesday, July 09, 2025
ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference
Posted On Wednesday, July 09, 2025
Altimmune Announces Initiation of RESTORE Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol-Associated Liver Disease (ALD)
Posted On Wednesday, July 09, 2025
Theratechnologies Reports Financial Results for the Second Quarter 2025
Posted On Wednesday, July 09, 2025
Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025
Posted On Wednesday, July 09, 2025
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
Posted On Wednesday, July 09, 2025
Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025
Posted On Wednesday, July 09, 2025
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
Posted On Wednesday, July 09, 2025
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan
Posted On Wednesday, July 09, 2025
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis
Posted On Wednesday, July 09, 2025
BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit
Posted On Wednesday, July 09, 2025
MEME Coins Inc. Finalizes DOG Token Acquisition from Tipestry Inc.
Posted On Wednesday, July 09, 2025

Print